Masters Speciality Pharma is proud to be sponsoring the category of Best Company in Emerging Markets at the 14th Annual Scrip Awards 2018. The award, officially known as Masters Speciality Pharma Best Company in an Emerging Market, will recognise research and development based pharmaceutical companies that are headquartered in an emerging market. The judges will be looking for excellence in performance across a range of business activities between June 1, 2017 and May 31, 2018. This could mean anything from growing sales and profits to launching new products, or signing a new deal.
Dr Zulf Masters, OBE, CEO and Founder of Masters, gave the following quote:
“We are delighted to team up with The Annual Scrip Awards 2018 to support this great initiative. Masters Speciality Pharma has had roots in the emerging markets since its foundation, over 34 years ago. To this day, we remain dedicated to providing excellence in medicines to patients who need them and join The Scrip Awards in recognising and rewarding our allies.”
Winners will be announced on November, 28th2018 at the award show taking place at The Hilton Park Lane in London. The Scrip Awards are judged by a panel of 17 respected judges from the pharmaceutical, biotech and life science sectors.